Avivagen offers scientifically-proven, nature-derived products that are helping livestock and pets. Our OxC-beta Livestock product is supporting productivity through enhanced feed flavor. Vivamune and Dr. Tobias All-in-One Dog chews support overall health and quality of life in dogs.
$0.44 per share
Please note that Avivagen’s fiscal year ends October 31st. For additional financial and corporate documents, please visit SEDAR here.
OxC-beta is easy-to-use because it comes as powder and is very affordable.
OxC-beta™ For Livestock – $1.2 Billion Tonne Annual Worldwide Market
Worldwide Purchase Orders
Avivagen is followed by the analysts listed below. Please note that any opinions, estimates or forecasts regarding Avivagen performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Avivagen or its management. By reference to the information below, Avivagen does not imply its endorsement of or concurrence with any information, conclusions or recommendations as a result of analyst coverage.
Doug Cooper, Beacon Securities Limited – (416) 643-3863
David Bautz, Zack’s Small Cap Research – (312) 265-9474
Avivagen offers its commercial partners scientifically backed, evidence-based products that are in high demand from multiple channels including veterinarians, farmers and producers, pet owners and retailers.
Avivagen maintains the highest manufacturing standards and is a proud member of the NASC, a self-regulating body, which protects and enhances the integrity of the animal health product industry.
Avivagen is actively collaborating with companies in Canada, the United States, Mexico, South Korea, Vietnam, Taiwan, Brazil, and Thailand, and we are seeking more relationships internationally.